Dee Baugher is a journalist for Modern Readers, specializing in financial news and analysis. With a focus on short interest updates and market trends, Dee provides readers with valuable insights into the world of finance and investment.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Dee's articles primarily focus on investment analysis and cite data extensively. She covers topics related to the stock market, stock prices, investments, trading, and ETFs.
Given her emphasis on investment analysis and citing data, Dee would likely be interested in receiving pitches from financial analysts or experts who can provide valuable insights into stock market trends, investment strategies, or specific company analyses. If you have proprietary data or unique perspectives that could contribute to understanding stock movements or investment opportunities, it might capture Dee's attention.
As there is no specified geographic focus for Dee's coverage area, she appears to have a broad international perspective regarding the topics she covers within the finance and investment realm.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Dee Baugher
Profitability This table compares Cellectis and NKGen Biotech's net margins, return on equity and return on assets. Net Margins
By: Dee Baugher
Hedge Funds Weigh In On Granite Point Mortgage Trust Several hedge funds have recently modified their holdings of GPMT. Price T Rowe Associates Inc.
By: Dee Baugher
Several other large investors have also recently added to or reduced their stakes in the business.
By: Dee Baugher
Other hedge funds also recently added to or reduced their stakes in the company. Ashton Thomas Private Wealth LLC acquired a new position in shares
By: Dee Baugher
Fiducian Group Price Performance The company has a quick ratio of 1.52, a current ratio of 2.69 and a debt-to-equity ratio of 5.47.
Other large investors have also bought and sold shares of the company. Capital World Investors lifted its holdings in shares of Merck & Co., Inc. by 67.6% in the first quarter.
By: Dee Baugher
Other hedge funds have also recently added to or reduced their stakes in the company. Valued Wealth Advisors LLC grew its holdings in Sherwin-Williams by 88.9% during the 3rd quarter.
By: Dee Baugher
Other institutional investors also recently bought and sold shares of the company. Hillsdale Investment Management Inc. increased its stake in American Express by 823.5% during the first quarter.
Elevance Health Stock Performance Elevance Health stock traded down $6.22 during mid-day trading on Tuesday, hitting $394.48.
By: Dee Baugher
Insider Transactions at Deckers Outdoor In other news, CFO Steven J. Fasching sold 8,802 shares of the company's stock in a transaction dated Friday, November 8th.
(833) 317-6278 
